QQQ $ 602.51 $ -2.70 (-0.45 %)
DIA $ 461.81 $ -1.56 (-0.34 %)
SPY $ 663.58 $ -3.31 (-0.5 %)
TLT $ 91.25 $ 0.75 (0.83 %)
GLD $ 394.68 $ 3.53 (0.9 %)
$ 0.012
-- x --
-- x --
-- - --
$ 0.01 - $ 2.45
240
na
2.13M
$ 0.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2024 09-30-2024 10-Q
2 08-08-2024 06-30-2024 10-Q
3 05-15-2024 03-31-2024 10-Q
4 04-01-2024 12-31-2023 10-K
5 11-14-2023 09-30-2023 10-Q
6 08-14-2023 06-30-2023 10-Q
7 05-15-2023 03-31-2023 10-Q
8 03-30-2023 12-31-2022 10-K
9 11-09-2022 09-30-2022 10-Q
10 08-11-2022 06-30-2022 10-Q
11 05-11-2022 03-31-2022 10-Q
12 03-31-2022 12-31-2021 10-K
13 11-15-2021 09-30-2021 10-Q
14 08-12-2021 06-30-2021 10-Q
15 05-06-2021 03-31-2021 10-Q
16 03-09-2021 12-31-2020 10-K
17 11-02-2020 09-30-2020 10-Q
18 08-10-2020 06-30-2020 10-Q
19 05-07-2020 03-31-2020 10-Q
20 03-12-2020 12-31-2019 10-K
21 11-04-2019 09-30-2019 10-Q
22 08-07-2019 06-30-2019 10-Q
23 05-10-2019 03-31-2019 10-Q
24 03-13-2019 12-31-2018 10-K
25 11-08-2018 09-30-2018 10-Q
26 08-02-2018 06-30-2018 10-Q
27 05-03-2018 03-31-2018 10-Q
28 03-07-2018 12-31-2017 10-K
29 11-07-2017 09-30-2017 10-Q
30 08-03-2017 06-30-2017 10-Q
31 05-04-2017 03-31-2017 10-Q
32 03-08-2017 12-31-2016 10-K
33 11-03-2016 09-30-2016 10-Q
34 08-04-2016 06-30-2016 10-Q
35 05-05-2016 03-31-2016 10-Q
36 03-09-2016 12-31-2015 10-K
37 11-10-2015 09-30-2015 10-Q
38 08-11-2015 06-30-2015 10-Q
39 05-07-2015 03-31-2015 10-Q
40 03-18-2015 12-31-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-downgrades-trevena-to-neutral-maintains-5-price-target

HC Wainwright & Co. analyst Douglas Tsao downgrades Trevena (OTC:TRVN) from Buy to Neutral and maintains $5 price target.

 trevena-q3-2024-gaap-eps-579-beats-738-estimate-sales-28300-down-from-18000k-yoy

Trevena (NASDAQ:TRVN) reported quarterly losses of $(5.79) per share which beat the analyst consensus estimate of $(7.38) by 21...

 why-trevena-trvn-stock-is-down-43-today

Trevena shares are trading lower by 47% during Monday's session. The company announced it received a Nasdaq delisting notif...

Core News & Articles

SRRK: 382% | Scholar Rock Holding shares are trading higher after the company announced topline results from the Phase 3 SAPPHI...

 trevena-receives-receipt-of-nasdaq-delisting-notification

Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines fo...

 reported-earlier-trevena-q2-eps-023-beats-040-estimate-sales-32500k-down-from-302m-yoy

Trevena (NASDAQ:TRVN) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.40) by 42...

 trevena-announces-1-for-25-reverse-stock-split-effective-tuesday-august-13-2024

Trevena, Inc. (NASDAQ:TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines fo...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION